AASLD is now accepting comments on proposed updates to AASLD's Practice Guidance on the Clinical Assessment and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (formerly NAFLD), which will now include new treatment guidance.
AASLD invites stakeholders to review the draft guidance updates before they are finalized and published by providing comments now through 8/22/24. While the writing group will consider all feedback submitted during the open comment period, please note that AASLD will not provide individual responses to reviewers.
The statements in the guidance update are in draft and not for use in practice until made final.
Thank you for taking the time to share your comments!